Inhibrx Biosciences, Inc.（INBX）内部人交易：高管与董事近期交易
过去 18 个月，共有 12 位内部人为 Inhibrx Biosciences, Inc.（INBX）报告了 43 笔 Form 4 交易（最近一笔 2026-09-28）。
| 日期 | 内部人 | 职务 | 类型 | 股数 | 市值 |
|---|---|---|---|---|---|
| 2026-09-28 | Lappe Mark | Chief Executive Officer | 买入 | 3,324 | $328,630 |
| 2026-09-28 | Lappe Mark | Chief Executive Officer | 买入 | 2,176 | $216,727 |
| 2026-09-28 | Lappe Mark | Chief Executive Officer | 买入 | 1,500 | $148,320 |
| 2026-09-28 | Lappe Mark | Chief Executive Officer | 买入 | 3,000 | $305,106 |
| 2026-09-23 | Kayyem Jon Faiz | 董事 | 买入 | 5,000 | $500,000 |
| 2026-09-17 | Kayyem Jon Faiz | 董事 | 买入 | 5,000 | $500,000 |
| 2026-09-15 | MANHARD KIMBERLY | 董事 | 卖出 | 500 | $55,888 |
| 2026-09-15 | MANHARD KIMBERLY | 董事 | 卖出 | 500 | $55,130 |
| 2026-09-15 | MANHARD KIMBERLY | 董事 | 卖出 | 500 | $52,525 |
| 2026-09-10 | MANHARD KIMBERLY | 董事 | 卖出 | 500 | $57,570 |
| 2026-09-10 | MANHARD KIMBERLY | 董事 | 卖出 | 500 | $57,898 |
| 2026-09-08 | FORSYTH DOUGLAS | 董事 | 买入 | 2,500 | $286,617 |
| 2026-09-08 | Kayyem Jon Faiz | 董事 | 买入 | 5,000 | $567,580 |
| 2026-09-08 | Lappe Mark | Chief Executive Officer | 买入 | 6,605 | $664,719 |
| 2026-09-08 | Lappe Mark | Chief Executive Officer | 买入 | 1,100 | $117,836 |
| 2026-09-08 | Lappe Mark | Chief Executive Officer | 买入 | 500 | $54,118 |
| 2026-09-08 | Lappe Mark | Chief Executive Officer | 买入 | 1,219 | $136,382 |
| 2026-09-08 | Lappe Mark | Chief Executive Officer | 买入 | 9,681 | $1.1M |
| 2026-09-08 | Lappe Mark | Chief Executive Officer | 买入 | 5,895 | $585,343 |
| 2025-10-09 | Viking Global Opportunities Illiquid Investments Sub-Master LP | 10% 以上股东 | 卖出 | 308,643 | $10.0M |
| 2025-10-09 | VIKING GLOBAL INVESTORS LP | 10% 以上股东 | 卖出 | 308,643 | $10.0M |
| 2025-10-09 | HALVORSEN OLE ANDREAS | 10% 以上股东 | 卖出 | 308,643 | $10.0M |
| 2025-10-09 | Ott David C. | 10% 以上股东 | 卖出 | 308,643 | $10.0M |
| 2025-10-09 | Viking Global Opportunities Portfolio GP LLC | 10% 以上股东 | 卖出 | 308,643 | $10.0M |
| 2025-10-09 | Viking Global Opportunities GP LLC | 10% 以上股东 | 卖出 | 308,643 | $10.0M |
来源：SEC Form 4 申报文件 · 截至 2026-09-28